| Application no. and date | 20186174.7 (espacenet) (Federated) (European Patent Register), 20151203 | | Patent/reg. no. and date | DK/EP 3763384, 20240828 | | Publication date | 20210113 | | Priority no. and date | EP 14196069, 20141203 | | EP pub. no. and date |
EP 3763384 20210113 | | Effective date | | | Applicant/owner | CSL Behring AG, Wankdorfstrasse 10
3014 Bern, CH | | Applicant ref. no. | PV1978DKEP | | Inventor | Styger, Regula, Asterweg 18
3004 Bern, CH,
Pedrussio, Renzo, Weierbuehlweg 5
3098 Koeniz, CH | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61M 5/178 (2006.01) , C07K 1/00 (2006.01) , C07K 16/00 (2006.01) | | Title | FARMACEUITISK PRODUKT MED ØGET STABILITET, OMFATTENDE IMMUNOGLOBULINER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
